Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary hyperparathyroidism.

Göran Akerström1, Per Hellman

  • 1Department of Surgery, University Hospital, Uppsala, Sweden. goran.akerstrom@kirurgi.uu.se

Current Opinion in Oncology
|December 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metformin inhibits small intestinal neuroendocrine tumor growth in vivo.

BMC cancer·2026
Same author

Single-Cell Comparison of Small Intestinal Neuroendocrine Tumors and Enterochromaffin Cells from Two Patients.

Cancers·2026
Same author

Emerging methods for subtype differentiation in primary aldosteronism.

Journal of internal medicine·2025
Same author

Loss of MBD2 is associated with tumor growth in small intestinal neuroendocrine tumors.

Endocrine connections·2025
Same author

Locoregional progression and surgical indications in stage IV asymptomatic SI-NETs.

Endocrine-related cancer·2025
Same author

Searching for peripheral proteomic markers of primary aldosteronism.

Endocrine·2025
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Primary hyperparathyroidism (pHPT) often requires surgery due to risks like osteoporosis and kidney stones. Advances in diagnostics and treatments offer improved management strategies for patients with this common endocrine disorder.

Area of Science:

  • Endocrinology
  • Surgical Oncology

Background:

  • Primary hyperparathyroidism (pHPT) is a common endocrine disorder.
  • It poses risks including osteoporosis, renal stones, and cardiovascular issues.

Purpose of the Study:

  • To review research progress in pHPT.
  • To discuss recent changes in treatment policy.

Main Methods:

  • Literature review of recent studies on pHPT.
  • Analysis of diagnostic and treatment advancements.

Main Results:

  • Surgery is often necessary for pHPT patients due to associated health risks.
  • Improved localization techniques support less invasive surgical options.
  • Medical treatment, including vitamin D, benefits older patients and those with bone mineral deficits.

Related Experiment Videos

Conclusions:

  • Surgical treatment for pHPT is highly effective, particularly in postmenopausal women.
  • Further research aims to elucidate disease causes and optimize treatment strategies.
  • There is growing interest in prophylaxis and personalized treatment approaches for pHPT.